surpass cvot tirzepatide SURPASS-CVOT shows delivers comparable cardiovascular safety to dulaglutide in patients with type 2 diabetes and established ASCVD, reinforcing the shift toward therapies that optimize whole cardiometabolic systems. As outcome datasets grow Read now: The SURPASS-EARLY trial

Horse Deficiencies In horses, this injection can improve general health in cases of tying-up syndrome

Frequently Asked Questions Does the 0.25 mg dose of Ozempic leave your system faster than higher doses

Your provider may also refer you to a reproductive endocrinologist if you have underlying fertility concerns or metabolic conditions

The antifungal agent ketoconazole has a dual role in hair loss compounding: it reduces Malassezia overgrowth on the scalp (a contributor to follicular inflammation and seborrheic dermatitis) and has demonstrated weak anti-androgenic properties

Age-related GHD in adults is treated with growth hormone therapy